Bristol-Myers Squibb Company
Viés de alta

$BMY with a Bullish outlook following its earnings #Stocks

The PEAD projected a Bullish outlook for BMY after a Negative over reaction following its earnings release placing the stock in drift C with an expected accuracy of 20%.

Aviso legal